Literature DB >> 15501745

Regulation of Candida albicans morphogenesis by fatty acid metabolites.

Mairi C Noverr1, Gary B Huffnagle.   

Abstract

Candida albicans is an opportunistic dimorphic fungus that inhabits various host mucosal sites. Conversion from the yeast to the hyphal form has been associated with increased virulence and mucosal invasiveness. C. albicans morphogenesis is regulated by multiple signals and signaling pathways. However, signals that control morphogenesis in vivo are unknown. We investigated the effects of host long chain fatty acids, eicosanoids, and bacterial short chain fatty acids on control of germination. None of the C18 or C20 fatty acids tested had an effect on enhancing germ tube formation (arachidonic acid, oleic acid, linolenic acid, or gamma-linolenic acid). Among the different eicosanoids, both prostaglandin E2 and thromboxane B2 significantly enhanced serum-induced germination by C. albicans. Addition of antiprostaglandin or antithromboxane antibodies to serum alone inhibited germ tube formation by almost 30%, while control antibody had no effect, indicating that these eicosanoids are major morphogenic factors in the serum. Since these molecules also bind to albumin, this may also explain the hyphal transforming activity in serum that associates with albumin. Interestingly, short chain fatty acids (butyric acid), the product of lactic acid bacteria (LAB), inhibited germination. In addition, LAB culture supernatants as well as live LAB also inhibited C. albicans morphogenesis. Overall, these results indicate that fatty acid metabolites and fatty acid pathways can up-regulate and down-regulate germination in C. albicans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501745      PMCID: PMC523025          DOI: 10.1128/IAI.72.11.6206-6210.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production.

Authors:  M D Säemann; G A Böhmig; C H Osterreicher; H Burtscher; O Parolini; C Diakos; J Stöckl; W H Hörl; G J Zlabinger
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

2.  Probiotic effects of feeding heat-killed Lactobacillus acidophilus and Lactobacillus casei to Candida albicans-colonized immunodeficient mice.

Authors:  R D Wagner; C Pierson; T Warner; M Dohnalek; M Hilty; E Balish
Journal:  J Food Prot       Date:  2000-05       Impact factor: 2.077

3.  Effects of orally administered viable Lactobacillus rhamnosus GG and Propionibacterium freudenreichii subsp. shermanii JS on mouse lymphocyte proliferation.

Authors:  P V Kirjavainen; H S ElNezami; S J Salminen; J T Ahokas; P F Wright
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Thromboxane A2 and prostaglandin H2 form covalently linked derivatives with human serum albumin.

Authors:  J Maclouf; H Kindahl; E Granström; B Samuelsson
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

5.  Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins.

Authors:  M C Noverr; S M Phare; G B Toews; M J Coffey; G B Huffnagle
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  The effect of oral bacteria on Candida albicans germ-tube formation.

Authors:  R G Nair; S Anil; L P Samaranayake
Journal:  APMIS       Date:  2001-02       Impact factor: 3.205

7.  Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages.

Authors:  M Miettinen; A Lehtonen; I Julkunen; S Matikainen
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  Prostaglandin D2 as a mediator of allergic asthma.

Authors:  T Matsuoka; M Hirata; H Tanaka; Y Takahashi; T Murata; K Kabashima; Y Sugimoto; T Kobayashi; F Ushikubi; Y Aze; N Eguchi; Y Urade; N Yoshida; K Kimura; A Mizoguchi; Y Honda; H Nagai; S Narumiya
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

Review 9.  Rationale for the luminal provision of butyrate in intestinal diseases.

Authors:  A Wächtershäuser; J Stein
Journal:  Eur J Nutr       Date:  2000-08       Impact factor: 5.614

10.  Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora.

Authors:  C Edlund; G Beyer; M Hiemer-Bau; S Ziege; H Lode; C E Nord
Journal:  Scand J Infect Dis       Date:  2000
View more
  81 in total

Review 1.  Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists.

Authors:  P Frey-Klett; P Burlinson; A Deveau; M Barret; M Tarkka; A Sarniguet
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

2.  Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy.

Authors:  Katie L Mason; John R Erb Downward; Kelly D Mason; Nicole R Falkowski; Kathryn A Eaton; John Y Kao; Vincent B Young; Gary B Huffnagle
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 3.  Immune defence against Candida fungal infections.

Authors:  Mihai G Netea; Leo A B Joosten; Jos W M van der Meer; Bart-Jan Kullberg; Frank L van de Veerdonk
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

4.  Calcineurin is required for Candida albicans to survive calcium stress in serum.

Authors:  Jill R Blankenship; Joseph Heitman
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 5.  Murine models of Candida gastrointestinal colonization and dissemination.

Authors:  Andrew Y Koh
Journal:  Eukaryot Cell       Date:  2013-09-13

Review 6.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

Review 7.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

8.  Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis.

Authors:  Katie L Mason; John R Erb Downward; Nicole R Falkowski; Vincent B Young; John Y Kao; Gary B Huffnagle
Journal:  Infect Immun       Date:  2011-10-10       Impact factor: 3.441

9.  Characterization of prostaglandin E2 production by Candida albicans.

Authors:  John R Erb-Downward; Mairi C Noverr
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

10.  Effect of marine polyunsaturated fatty acids on biofilm formation of Candida albicans and Candida dubliniensis.

Authors:  Vuyisile S Thibane; Johan L F Kock; Ruan Ells; Pieter W J van Wyk; Carolina H Pohl
Journal:  Mar Drugs       Date:  2010-10-08       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.